Immune responses following meningococcal serogroups A, C, Y and W polysaccharide vaccination in C2-deficient persons: Evidence for increased levels of serum bactericidal antibodies.

Summary, in English

Complement C2 deficiency (C2D) is associated with immunological diseases and increased susceptibility to invasive infections caused by encapsulated bacteria such as Neisseria menigitidis. In this study we evaluate the immunogenicity of vaccination against N. menigitidis in C2D. C2D patients (n=22) and controls (n=52) were given a tetravalent meningococcal polysaccharide vaccine. Serum bactericidal antibody (SBA) titres (serogroups A, C, Y and W) were analysed using a rabbit complement source. Levels of IgG, IgM, and IgA, factor B, and factor H, polymorphisms of MBL and Fc-gamma receptors were determined. The C2D patients responded with an increased SBA titre to all four serogroups (p<0.001). The response rates define as SBA titres ≥8 were found to be between 85.7% and 92.5%. The post-vaccination titres for serogroups C, Y and W were equal to healthy controls. C2D patients with a history of invasive infection had a lower post-vaccination SBA titres both compared to healthy C2D persons (p=0.03) and compared to controls (p<0.0001). We found that the G2M*n/G2M*n genotype were associated with a higher SBA titres after immunization (p=0.03). None of the other investigated immunological factors appear to be important in influencing the vaccine responses. Autoimmune diseases in C2D did not affect the vaccine response. In general, vaccination against meningococci gave rise to antibody responses in the C2D patients that equal healthy controls. The response rate was lower to serogroup A and among C2D patients with history of invasive infections. The presence of G2M*n/G2M*n genotype was associated with higher SBA titres after immunization.

• Författare: Nicholas Brodszki; Lillemor Melander Skattum; Xilian Bai; Helen Findlow; Ray Borrow; Göran Jönsson
• Avdelning/ar: Pediatrik, Lund; Avdelningen för mikrobiologi, immunologi och glykobiologi - MIG
• Publiceringsår: 2015
• Språk: Engelska
• Sidor: 1839-1845
• Publikation/Tidskrift/Serie: Vaccine
• Volym: 33
• Issue: 15
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/25707694?dopt=Abstract; http://dx.doi.org/10.1016/j.vaccine.2015.02.025
• Dokumenttyp: Artikel i tidskrift
• Förlag: Elsevier
• Ämne: Pediatrics; Microbiology in the medical area; Immunology in the medical area
• Status: Published
• ISBN/ISSN/Övrigt: ISSN: 1873-2518